Similar Papers

Paper Title
Journal
Date
Author
1577P Optimizing the management of PARP inhibitors in clinical practice: Results of a DELPHI French consensus
F Selle ... A Floquet
Annals of Oncology | VOL. 33
F Selle, et. al.F Selle ... A Floquet
01 Sep 2022
Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
Zheng-Hang Wang ... Lin Shen
Chronic Diseases and Translational Medicine | VOL. 4
Zheng-Hang Wang, et. al.Zheng-Hang Wang ... Lin Shen
01 Mar 2018
Endoscopic devices and techniques for the management of bariatric surgical adverse events (with videos)
Allison R Schulman ... David R Lichtenstein
Gastrointestinal Endoscopy | VOL. 92
Allison R Schulman, et. al.Allison R Schulman ... David R Lichtenstein
13 Aug 2020
The treatment with pasireotide in Cushing\u2019s disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center
C Simeoli ... D Angellotti
Journal of Endocrinological Investigation | VOL. 43
C Simeoli, et. al.C Simeoli ... D Angellotti
16 Jul 2019
View more papers

More From: Community Oncology

Paper Title
Journal
Date
Author
Emerging therapies for melanoma
Sewa Legha
Community Oncology | VOL. 10
Sewa LeghaSewa Legha
01 Dec 2013
Anti-PD-1 antibodies in melanoma
Jame Abraham ... Matt Stenger
Community Oncology | VOL. 10
Jame Abraham, et. al.Jame Abraham ... Matt Stenger
01 Dec 2013
Multimodality therapy for uterine serous carcinoma and the association with overall and relapse-free survival
Himanshu Nagar ... Dattatreyudu Nori
Community Oncology | VOL. 10
Himanshu Nagar, et. al.Himanshu Nagar ... Dattatreyudu Nori
01 Dec 2013
Key issues in the management of gastrointestinal immune-related adverse events associated with ipilimumab administration
Mario Sznol ... Jedd Wolchok
Community Oncology | VOL. 10
Mario Sznol, et. al.Mario Sznol ... Jedd Wolchok
01 Dec 2013
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.